华熙生物：大股东国寿成达减持致权益变动触及5%刻度

Core Viewpoint - The major shareholder Guoshou Chengda of Huaxi Bio announced a share reduction plan, which will not change the company's controlling shareholder or actual controller [1] Group 1 - Guoshou Chengda plans to reduce its holdings from November 26, 2025, to January 7, 2026, by selling 2,844,591 shares through centralized bidding, accounting for 0.59% of the total shares [1] - On January 6, 2026, Guoshou Chengda will further reduce its holdings by selling 2,008,000 shares through block trading, representing 0.42% of the total shares [1] - The total reduction amounts to 4,852,591 shares, which is 1.01% of the total share capital [1] Group 2 - After the share reduction, Guoshou Chengda will hold 24,083,913 shares, which is approximately 5.00% of the total share capital [1] - The share reduction plan has not yet been fully implemented [1]